|
Open |
All Faculty |
Non-Federal |
Clinical Trials |
The Gateway's Research Funding Program
Supports patient-centered research having a positive impact the lives of cancer patients.
Due Date:
|
Open
|
Amount & Project Period:
|
Applicants should apply for the amount they believe is needed to
conduct their clinical trials and indicate the amount of time
necessary to successfully complete the research study.
|
Eligibility:
|
All Faculty
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
Gateway
for Cancer Research Funding Program
|
|
|
UPDATED DEADLINE! |
Jan 27 |
Faculty, Research & Staff Scientists
|
Internal |
Technology & Cores |
Technology & Cores Funding Opportunities
There are two available opportunities:
Innovative Core Projects To provide dedicated research time to develop a new technology or the operational procedures
of a new core instrument that will lead to new core services.
Core and Technical Staff Travel Awards To provide educational, training, and networking opportunities related to new
technologies for Core and Technical Staff.
Due Date:
|
Ongoing
|
Amount & Project Period:
|
Innovative Core Projects: $60,000 (tied to funding milestones of $10K)
Core and Technical Staff Travel Awards: There is no formal cap, but all proposed costs
must be fully justified
|
Eligibility:
|
All Faculty, Research Scientists, Staff Scientists
|
Contact:
|
Maureen Ahearn (x8824)
|
|
|
|
Jan 6 |
Jr. Faculty |
Non-federal |
Drug Development |
McKnight Endowment Fund for Neuroscience - 2014 McKnight
Neuroscience Scholar Awards
Innovative research to bring science closer to the time when diseases of the brain can be accurately diagnosed, prevented, and treated.
|
|
Jan 06 (LOI) |
All Ranks |
Federal |
Palliative Care |
The Palliative Care Research Cooperative (PCRC): Enhancing Sustainability and Building the Science of Palliative Care (R01)
Enhance research and resource activities of the PCRC. Proposed studies must be designed to use PCRC infrastructure and resources to accomplish aims.
Due Date:
|
January 06 (Letter of Intent)
February 06 (Application due)
|
Amount & Project Period:
|
$350,000/year (Direct Costs) - 4 years |
Eligibility:
|
All Ranks
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
RFA-NR-14-003
|
|
|
Jan 06 (LOI) |
All Faculty |
Federal |
Evidence-based Health Care |
Deliberative Approaches: Patient and Consumer Input for Implementing Evidence-based Health Care (R21)
Use deliberative methods to understand and clarify important public or patient values and concerns
affecting the implementation of specific interventions, programs or policies to improve health care or research.
Due Date:
|
January 06 (Letter of Intent)
February 07 (Application Due)
|
Amount & Project Period:
|
$400,000 (TOTAL Costs) – 2 years
|
Eligibility:
|
All Faculty
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
RFA-HS-14-007
|
|
|
Jan 08 |
Postdocs/Fellows |
Non-federal |
Brain |
Basic Research Fellowship
Applicants on-track to pursue a career in brain tumor research with a sponsor who has a
demonstrated history of brain tumor research and mentorship.
|
|
Jan 7 |
All Faculty |
Federal |
Malignancies & HIV/AIDS |
Research on Malignancies in the Context of HIV/AIDS
Research encouraged in areas such as the study of the etiologic factors, cofactors, immunopathogenesis,
diagnosis, and consequences of both non-AIDS defining and AIDS-defining malignancies in diverse populations.
Due Date:
|
January 7
|
Amount & Project Period:
|
R01: Unlimited Budget - 5 years
R21: $275,000 (Direct Costs) - 2 years
|
Eligibility:
|
All Ranks
|
Contact:
|
Linda Nolan,
(x6071)
|
FOA Links:
|
R21: PA-13-378
R01:
PA-13-377
|
|
|
|
NEW OPPORTUNITY |
Jan 8 |
All Ranks |
Non-federal |
Pancreatic |
Research Grants
Studies intended to advance knowledge in the areas of pancreatic carcinoma, and all forms of pancreatitis would be the closest to the areas of interest of the NPF.
|
NEW OPPORTUNITY |
Jan 10 |
Postdocs |
Non-federal |
Lymphoma |
Postdoctoral Fellowship Awards Program 2014 Cycle
Basic, translational or clinical investigations into normal and aberrant lymphatic biology; mechanisms of normal and pathological lymphangiogenesis; imaging and understanding the mechanisms that regulate lymphatic structure and function; animal models of lymphatic system disorders; and the cross-talk between the lymphatic and the immune systems.
Due Date:
|
January 10
|
Amount & Project Period:
|
$82,000 - $95,000 - 2 years
|
Eligibility:
|
Must hold a Ph.D. and/or M.D. or equivalent degree Must have completed
at least 3 years of full-time postdoc experience by July 1, 2014. |
Contact:
|
Linda Nolan,(x6071)
|
RFA Link:
|
Postdoctoral Fellowship Awards Program
|
|
|
|
|
Jan 13 |
Jr. Faculty |
Non-federal |
Ovarian |
Young Investigator Grants
Support career development for qualified individuals who wish to establish a career in the area of Ovarian Cancer Research.
Due Date:
|
January 13
|
Amount & Project Period:
|
$50,000 - 1 year
|
Eligibility:
|
1. A post-doc fellow or assistant professor within 5 years (excluding clinical training) of completing his/her terminal degree.
2. An assistant professor (or equivalent) within 3 years of initiating independent research
|
Contact:
|
Shaina Sine (x3658)
|
RFA Link:
|
Young Investigator Grants
|
|
|
Jan 13 |
Established Investigators |
Non-federal |
Ovarian |
General Research Grants
Either individual projects or part of a larger project related to ovarian cancer. Clinical trials should be original investigational studies related to ovarian cancer in which the grantee is the PI or Co-PI.
|
|
Jan 14 (LOI)
Feb 14 (Application) |
All Faculty |
Federal |
GxE interactions |
Analysis of Genome-wide Gene-environment (GxE) Interactions (R21)
Projects involving secondary analysis of existing genome-wide data from genome-wide association studies
or other large genomic datasets to identify gene-environment interactions.
Due Date:
|
January 14 (Letter of Intent)
February 14 (Application)
|
Amount & Project Period:
|
1.
Applications requesting 3 years are limited to direct costs of $300,000 over the 3-year period
2. A combined budget for direct costs for a 2-year project period may not exceed $275,000
3. No more than $200,000 may be requested in any single year
|
Eligibility:
|
All Faculty
|
Contact:
|
Linda Nolan,
(x6071)
|
RFA Link:
|
PAR-13-382 |
|
|
|
LIMITED SUBMISSION! |
Jan 15 |
Postdoc/Fellows |
Non-federal |
Translational |
AACI Translational Cancer Research Fellowship
(Limited Submission)
Support to individuals engaged in any area of clinical
and/or translational cancer research
Due Date:
|
January 15 (Internal Deadline) Submit to
Maureen Ahearn Sponsor Deadline: February 3
|
Amount & Project Period:
|
$50,000 - 1 year |
Eligibility:
|
Postdocs/Fellows - must be in first 5 years of postdoctoral or clinical research fellowship
|
Contact:
|
Maureen Ahearn, x8824
|
RFA Link:
|
AACI
Cancer Research Fellowship
|
|
NEW OPPORTUNITY |
Jan 15 (Pre-application) |
Jr. Faculty |
Non-federal |
Health Disparities |
New Connections: Increasing Diversity of RWJF Programming - Junior Investigators
Support and training to Junior Investigators to research projects addressing health disparities (this year's focus for New Connections)
Due Date:
|
January 15 (Pre-application)
|
Amount & Project Period:
|
$100,000 – 24 months |
Eligibility:
|
Jr. Faculty (from historically disadvantaged and underrepresented communities)
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
2013 Call
for Proposals
|
|
|
Jan 15 |
Jr. faculty |
Non-federal |
Radiology |
Research Scholar Grant
To support junior faculty members who have completed the conventional resident/fellowship training
programs but have not yet been recognized as independent investigators.
Due Date:
|
January 15
|
Amount & Project Period:
|
$75,000/yr - 2 years (Salary Support)
|
Eligibility:
|
Junior Faculty (Must be an RSNA member at time of application)
|
Contact:
|
Shaina Sine (x3658) |
RFA Link:
|
Research Scholar Grant |
|
|
Research Seed Grant
To gain experience in defining objectives and testing hypotheses in preparation for major grant applications to corporations, foundations and governmental agencies.
|
|
Jan 17 |
Jr. faculty |
Non-federal |
Digestive Cancers |
AGA-Caroline Craig Augustyn & Damian Augustyn
Award in Digestive Cancer
To support young investigators conducting research relevant to the pathogenesis, prevention, diagnosis, or treatment of digestive cancer.
The award is intended to supplement existing career development funding.
Due Date:
|
January 17
|
Amount & Project Period:
|
$40,000 - 1 year
|
Eligibility:
|
Junior Faculty who currently hold a federal or non-federal career development award devoted to research related to digestive cancer |
Contact:
|
Linda Nolan,
(x6071)
|
RFA Link:
|
http://www.gastro.org/aga-foundation/grants/
|
|
NEW OPPORTUNITY |
Jan 20 (LOI)
Feb 20 (Application) |
All Ranks |
Federal |
Molecular Analysis |
Early-Stage Innovative Molecular Analysis Technology Development for Cancer Research (R21)
Exploratory research projects focused on the inception and development of early stage,
highly innovative, technologies for the molecular or cellular analysis of cancer.
Due Date:
|
January 20 (Letter of intent)
February 20 (Application Due)
|
Amount & Project Period:
|
$500,000 (Direct Costs) -3 years |
Eligibility:
|
All Ranks
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
RFA-CA-14-003
|
|
NEW OPPORTUNITY |
Jan 20 (LOI)
Feb 20 (Application Due) |
All Ranks |
Federal |
Molecular Analysis |
Validation and Advanced Development of Emerging Molecular Analysis Technologies for
Cancer Research (R33)
Research projects on the advanced development of emerging molecular and cellular analysis technologies and technical/analytical validation in an appropriate cancer-relevant biological system.
Due Date:
|
January 20 (Letter of Intent)
February 20 (Application Due)
|
Amount & Project Period:
|
$300,000/year (Direct Costs) - 3 years
|
Eligibility:
|
All Ranks
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
RFA-CA-14-004
|
|
NEW OPPORTUNITY |
Jan 20 (LOI)
Feb 20 (Application) |
All Ranks |
Federal |
Biospecimen Science |
Early Stage Development of Innovative Technologies for Biospecimen Science (R21)
Goal is to develop technologies capable of interrogating and/or maximizing the quality and utility of biospecimens or samples derived from those biospecimens for downstream analyses.
Due Date:
|
January 20 (Letter of Intent)
February 20 (Application Due)
|
Amount & Project Period:
|
$500,000 (Direct Costs) - 3 years
|
Eligibility:
|
All Ranks
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
RFA-CA-14-005
|
|
|
Jan 20 (LOI)
Feb 20 (Application) |
All Ranks |
Federal |
Biospecimen Science |
Validation and Advanced Development of Emerging Technologies for Biospecimen Science (R33)
Goal is to develop technologies capable of interrogating and/or maximizing the quality and utility of biospecimens or their derived samples for downstream analyses.
Due Date:
|
January 20 (Letter of Intent)
February 20 (Application Due)
|
Amount & Project Period:
|
$300,000/year (Direct Costs) - 3 years
|
Eligibility:
|
All Ranks
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
RFA-CA-14-006
|
|
INTERNAL FUNDING
OPPORTUNITY |
Jan 21 |
All Faculty |
Intramural Funding |
Personalized Medicine |
Pilot Research Grants in Personalized Medicine
Funding for Pilot Research Grants with the goal of developing competitive Federal, State or DOD applications in the area of Personalized Medicine.
|
|
Jan 21 (EXTENDED DUE DATE) |
All Ranks |
Non-federal |
PCOR |
Winter Cycle 2014
PCORI is in the process of revising application due dates in order to transition from 3 to 4 funding cycles per year.
Therefore, the deadline for the initiatives listed below has been extended to January 21, 2014.
The LOI deadline for this cycle was October 15th.
|
|
Jan 25 |
All faculty |
Federal |
Training |
Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32)
Program to enhance pre-doctoral and postdoctoral research training, including short-term research training.
Due Date:
|
Standard Dates (Next is January 25)
|
Amount & Project Period:
|
Depending on number of trainees approved, award provides stipends and contributes to costs of tuition and fees, trainee travel, and other research training expenses
Duration: 5 years
|
Eligibility:
|
All Faculty |
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
PA-14-015
|
|
|
Jan 30 |
Funded PIs |
Federal |
Analytical Chemistry |
Administrative Supplements to NIH Awards for Validation Studies of Analytical Methods for Natural Products
Administrative supplements to provide funds to NCI-supported research projects. The NCI Biomarkers Research Group is particularly interested in validation of quantitative analytical methods for dietary supplement metabolites in human or animal species that may also be useful indicators of particular metabolic, physiologic or pathological states.
Due Date:
|
January 30
|
Amount & Project Period:
|
1. No more than 25% of the Council-approved direct costs for the current budget year or $100,000 (total direct costs) whichever is less.
2. May be requested for up to one year and must be within the currently approved project period for the existing parent award.
3. Parent award must be active and research proposed must be accomplished within the competitive segment.
|
Eligibility:
|
Supplement must be to provide for an increase in costs due to unforeseen
circumstances. All additional costs must be within the scope of the peer reviewed and approved project.
|
Contact:
|
Linda Nolan,
(x6071)
|
RFA Link:
|
PA-13-381
|
|
|
|
|
Jan 31 |
All Faculty |
Non-federal |
Sarcoma |
The Sarcoma Foundation of America - Research Grants
Translational sarcoma research on the etiology, molecular biology, pathogenesis, diagnosis, and treatment of human sarcomas.
|
NEW OPPORTUNITY |
Jan 31 |
All Ranks |
Non-Federal |
Breast |
The Florida Breast Cancer Foundation - Research Grants
Designated Scientific Research Grant themes are:
1. Environmental factors and breast cancer in Florida
2. Novel epidemiological studies to provide insight on opportunities for improving breast cancer detection and treatment in Florida.
3. Psycho-immunologic mechanisms and breast cancer progression:
implications for improving outcomes.
|
NEW OPPORTUNITY |
Feb 03 |
Postdocs |
Non-federal |
Career Development |
The Jane Coffin Childs Memorial Fund for Medical
Research - Postdoctoral Fellowship
Research into the causes, origins and treatment of cancer.
|
|
Feb 03 (LOI)
March 03 (Applications due) |
All Ranks |
Federal |
Epigenomics |
Computational Analyses Exploiting Reference Epigenomic Maps (R01)
Computational analyses that will take advantage of the publicly available reference epigenomic maps generated as part of the Roadmap Epigenomics Program.
Due Date:
|
February 03 (Letter of Intent)
March 03 (Applications due)
|
Amount & Project Period:
|
$200,000/year (Direct Costs) – 2 years |
Eligibility:
|
All Ranks
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
RFA-RM-14-001
|
|
R01 Parent - Cycle I Due Date for NEW
investigator-initiated proposals |
Feb 5 |
All Ranks |
Federal |
Investigator-initiated |
Research Project Grants
This is one of 3 dates for submission of NEW investigator-initiated R01s.
It will support a discrete, specified, circumscribed project to be performed by the named investigator(s)
in areas representing the specific interests and competencies of the investigator(s).
Due Date:
|
February 5
|
Amount & Project Period:
|
Budgets not limited - 5 years |
Eligibility:
|
All Ranks
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
PA-13-302
|
|
|
|
NEW OPPORTUNITY |
Feb 05 |
All Ranks |
Federal
|
Assays for HTS
|
Development of Assays for High-Throughput Screening for Use in Probe and Pre-therapeutic Discovery
To stimulate research in:
1) Developing assays for specific biological targets and disease mechanisms relevant to the mission of participating NIH
Institutes with the intent to screen for small molecule compounds that show potential as probes for use in advancing knowledge about the known targets,
identifying new targets, or as pre-therapeutic leads; and
2) Establishing collaboration with screening centers that have the requisite expertise and
experience needed in implementation of HTS assays for the discovery and development of small molecule chemical probes.
|
|
Feb 5 |
All Faculty |
Federal |
In vivo Imaging |
Academic-Industrial Partnerships for translation of in vivo Imaging Systems for Cancer Investigations
Applications from research partnerships formed by academic and industrial investigators to accelerate the translation of either preclinical or clinical
in vivo imaging systems and/or methods that are designed to solve a targeted cancer problem.
|
|
Feb 5 |
All Faculty |
Federal |
Tumor Therapies |
Quantitative Imaging for Evaluation of Response to Cancer Therapies
To promote research on quantitative imaging of tumor response to cancer therapies in clinical trial settings, with
the overall goal of facilitating clinical decision making.
|
|
Feb 5 (R01)
Feb 16 (R21) |
All Ranks |
Federal |
Nanotechnology |
Nanoscience and Nanotechnology in Biology and Medicine
Encourages applications from institutions/organizations that apply nanoscience and nanotechnology approaches to address problems in biology and medicine.
Due Date:
|
Standard Dates Apply
R01: February 5
R21: February 16
|
Amount & Project Period:
|
R01: Budgets not limited - 5 years
R21: $275,000 (Total Direct Costs) - 2 years
|
Eligibility:
|
All Ranks
|
Contact:
|
Linda Nolan,(x6071)
|
RFA Link:
|
R01:
PA-11-148
R21: PA-11-149
|
|
|
Feb 5 (RO1)
Feb 16 (R21) |
All Ranks |
Federal |
Cancer & Aging |
Translational Research at the Aging/Cancer Interface (TRACI)
Proposals in the overlapping areas of human aging and cancer, linking basic and clinical research relevant to the care of older
cancer patients through both bench-to-bedside and bedside-to-bench approaches.
Due Date:
|
Standard
Dates Apply
R01: February 05
R21: February 16
|
Amount & Project Period:
|
R01: Budgets not limited - 5 years
R21: $275,000 (Total Direct Costs) - 2 years
|
Eligibility:
|
All Ranks
|
Contact:
|
Linda Nolan,
(x6071)
|
RFA Link:
|
R01:
PA-12-136
R21: PA-12-135
|
|
|
Feb 05 |
All Ranks |
Federal |
Oral/Craniofacial |
Establishing Outcome Measures for Clinical Studies of Oral and Craniofacial Diseases and Conditions
To support the development of well-founded outcome measures, including establishing their reliability and validity,
for clinical studies of oral and craniofacial diseases and conditions.
|
|
Feb 05 |
All Ranks |
Federal |
Tobacco-related
Health Outcomes |
Nutrition and Alcohol-related Health Outcomes (R01)
To stimulate broad research on the role of nutrition in the development, prevention, and treatment of a variety of alcohol-related health outcomes including chronic disease.
|
|
R01: Feb 05
R21: Feb 16 |
All Faculty |
Federal |
Chemical Probes |
Solicitation of Assays for High Throughput Screening (HTS) to Discover Chemical Probes
NCI interest: High throughput screens intended to:
• identify small molecules for use in elucidating molecular, cellular, or in vivo mechanisms or processes of probable or known importance to cancer biology, and
• intended for use in developing strategies for cancer prevention, diagnosis, treatment or clinical monitoring of treatment.
Due Date:
|
Standard Dates Apply
Next R01: February 05
Next R21: February 16
|
Amount & Project Period:
|
R01: Budget unlimited – 3 years
R21: $275,000 Direct Costs – 2 years
|
Eligibility:
|
All Faculty
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
R01:
PAR-12-058
R21: PAR-12-059
|
|
|
|
|
Feb 05 |
All Ranks |
Federal |
Assay Development |
Development of Assays for High-Throughput Screening for Use in Probe and Pre-therapeutic Discovery (R01)
NCI Interest: development of assays to identify or evaluate small molecules for use in elucidating molecular, cellular, or in vivo mechanisms or processes important to cancer biology, and for use in developing strategies for cancer prevention, diagnosis, treatment or clinical monitoring of treatment.
|
|
Feb 05 |
All Faculty |
Federal |
Behavior |
Modeling Social Behavior (R01)
Transdisciplinary teams of scientists spanning a broad range of expertise. Applications from cross-trained
investigators with expertise in complex systems and computational thinking and approaches (such as computational
neuroscientists, computational sociolinguists, computational anthropologists, computational epidemiologists, etc.)
are encouraged. Applications should demonstrate bridge-building between disciplines, scales and levels.
Due Date:
|
Standard dates Apply
Next: February 05
|
Amount & Project Period:
|
Budgets are not limited
5 years for New & Early Stage Investigators
4 years for Established Investigators
|
Eligibility:
|
All Faculty
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
PAR-13-374
|
|
NEW OPPORTUNITY |
Feb 05 |
All Ranks |
Non-federal |
Pancreatic |
Pancreatic Cancer Convergence Dream Team Translational Research Grant
A translational cancer research project addressing critical problems in pancreatic cancer patient care, including therapeutic
interventions for pancreatic cancer, and delivery
of near-term patient benefit.
Due Date:
|
February 05
|
Amount & Project Period:
|
$8,000,000 (TOTAL) over 3 years
|
Eligibility:
|
All Ranks - Must include laboratory and clinical researchers, senior and/or young investigators, and senior scientists who have not worked together in the past
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
Program Guidelines and Application Instructions
|
|
|
Feb 06 |
Principal Investigators |
Federal |
Sex/Gender Differences |
Administrative Supplements for Research on
Sex/Gender Differences (Admin Supp.)
Preclinical, clinical and behavioral studies relevant to molecular and cellular and systems
biology bases of disease and pathophysiology, clinical presentation, and prevention and treatment of disease.
Due Date:
|
February 06
|
Amount & Project Period:
|
$100,000/total costs – 12 months (must be within the approved period of parent award)
|
Eligibility:
|
Must hold an active grant or cooperative agreement, and research proposed must be accomplished within the competitive segment of the active award
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
PA-14-027
|
|
|
Feb 12 |
All Ranks |
Federal |
Career Development |
NCI Mentored Research Scientist Development Award to Promote Diversity
Career development experience in the biomedical, behavioral, or clinical sciences leading to
research independence for individuals representative of groups that have been shown to be underrepresented in health-related science.
Due Date:
|
Standard Dates Apply
Next: February 12
|
Amount & Project Period:
|
Up to $100,000/year toward salary of recipient
$30,000/yr. for research development costs;
5 years
|
Eligibility:
|
Jr. Faculty
• Individuals from racial and ethnic groups underrepresented in health-related sciences;
• Individuals with disabilities;
• Individuals who come from a family w/an annual income below established low-income thresholds
|
RFA Link:
|
PAR-12-050
|
NCI Established Investigator Award in Cancer Prevention and Control (K05)
Protected time for senior investigators w/exceptional mentoring records and sustained, high levels of
research productivity in cancer prevention, cancer control to devote to research and mentoring.
Amount & Project Period:
|
25%FTE salary costs/year;
$25,000/yr. (Direct Costs) - $5,000 per mentee, for up to 5 mentees for expenses directly resulting from mentored activities
5 years
|
Eligibility:
|
Established Investigators
|
RFA Link:
|
PAR-12-065
|
|
|
NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity
To prepare individuals for careers having a significant impact on health-related research.
Amount & Project Period:
|
Up to $100,000/year toward salary of recipient $30,000/yr. for research
development costs
|
Eligibility:
|
Jr. Clinical Faculty - specifically, clinical scientists from diverse backgrounds that have been shown to be underrepresented in health-related science
5 years
|
RFA Link:
|
PAR-12-051
|
|
|
NCI Transition Career Development Award (K22)
Facilitates the transition of investigators in mentored non-independent cancer research positions to independent faculty cancer research positions.
Amount & Project Period:
|
$100,000/yr. for salary costs
$50,000/year for research costs
3 years
|
Eligibility:
|
Jr. Faculty
w/at least 2 years postdoc training in cancer research at time of proposal submission;
w/8 years or less of mentored non-independent research training experience after the terminal clinical or research doctorate at time of proposal submission |
RFA Link:
|
PAR-12-121
|
|
|
NCI Mentored Patient-Oriented Research Career Development Award to Promote Diversity (K23)
Provides support and "protected time" to non-tenured clinician-scientists interested in mentored patient-oriented cancer research.
Amount & Project Period:
|
Salary Support: Up to $100,000 plus fringe benefits/ year
Research Support: $30,000/year
3-5 years
|
Eligibility:
|
Candidates must have a clinical degree and practice clinically
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
PAR-12-052
|
|
NEW OPPORTUNITY |
Feb 12 |
All Faculty |
Non-federal |
HPV |
Human Papillomavirus (HPV) Translational Research Team
Translational cancer research on critical problems in HPV-related cancers, including plans on how work can be translated to clinic and deliver near-term benefits to patients.
|
NEW OPPORTUNITY |
Feb 15 (LOI) |
All Ranks |
Non-federal |
Translational Research |
Translational Research Program
Funding priorities:
1. Define genetic/molecular predispositions to long-term and late-term effects associated with standard therapies in pediatric ALL and apply this information to improve patient outcomes
2. Development of novel therapeutic strategies for non-cutaneous T-cell lymphoproliferative disorders
3. Develop novel targeted therapies for CLL patients
4. Develop novel treatment strategies for MDS patients
5. Develop novel targeted therapies for high-risk myeloma
6. New-targeted therapies for indolent lymphoma patients
|
Feb 15 |
Jr. Clinical Investigators |
Non-federal |
Career Development |
Mentored Research Training Grant
Research Areas: Basic Science (MRTG-BS);
Clinical and Translational (MRTG-CT); & Health Services Research (MRTG-HSR)
Purpose: To help anesthesiologists develop the skills and preliminary data to become independent investigators.
|
|
Feb 15 |
Fellows |
Non-federal |
Career Development |
Research Fellowship Grant
Research Areas: Basic Science, Clinical and Translational, Health Services or Education
Purpose: To provide significant training in research techniques and scientific methods.
|
R21 - Parent - Cycle
I Due Date for New Proposals
|
Feb 16 |
All Ranks |
Federal |
Res Development |
NIH Exploratory/Developmental Research Grant Program (Parent R21)
The R21 mechanism is intended to encourage exploratory and developmental research projects.
The R03 mechanism supports different types of projects including pilot & feasibility studies;
secondary analysis of existing data; small self-contained research projects; development of research
methodology and development of new research technology.
Due Date:
|
February 16
|
Amount & Project Period:
|
R21: Unless otherwise specified: $275,000 direct costs - 2 years
R03: Unless otherwise specified, $100,000 direct costs - 2 years |
Eligibility:
|
All Ranks |
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
R21:
PA-13-303
R03:
PA-13-304
These are parent announcements; NCI does not necessarily participate.
There are topic-specific funding opportunities that utilize these mechanisms. |
|
|
Feb 16 |
All Ranks |
Federal |
Nutrition |
Nutrition and Alcohol-related Health Outcomes
To stimulate broad research on the toll of nutrition in the development, prevention, and treatment of a variety of alcohol-related health outcomes including chronic disease.
Due Date:
|
Standard Dates Apply
Next: February 16
|
Amount & Project Period:
|
R21: $275,000 (Total Direct Costs) - 2 years
R03: $100,000 (Total Direct Costs) - 2 years
|
Eligibility:
|
All Ranks |
Contact:
|
Linda Nolan,
(x6071)
|
RFA Link:
|
R21:
PA-13-361
R03: PA-13-360
|
NEW OPPORTUNITY |
Feb 16 |
All Ranks |
Federal |
Health Information (IT) |
Exploratory and Developmental Grant to Improve Health
Care Quality Through Health Information (IT) (R21)
Fund exploratory and developmental research grants that will contribute to the evidence base of how health IT
improves health care quality.
|
NEW OPPORTUNITY |
Feb 17 |
Jr. Faculty |
Non-federal |
Leukemia |
Hollis Brownstein Research Grants
Exclusively new investigators - starting to establish laboratories and no longer under mentorship.
Due Date:
|
February 17
|
Amount & Project Period:
|
$100,000
1 year
|
Eligibility:
|
Jr. Faculty - w/in 7 years of first independent position. Years as a resident physician, fellow physician, or post-doctoral fellow are considered to be training years
SEE ANNOUNCMENT FOR EXCLUSIONS
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
Hollis Brownstein Research Grants Program
|
|
|
Feb 19 (LOI)
March 19 (App) |
Established Faculty |
Federal |
Health Disparities |
Feasibility Studies to Build Collaborative Partnerships in Cancer Research
Collaborative partnership awards between institutions serving communities with cancer health disparities and NCI-designated Cancer
Centers (or groups of Centers). "Institutions" refer to academic or other organizations serving communities with cancer health disparities.
Due Date:
|
February 19 (Letter of Intent)
March 19 (Applications)
|
Amount & Project Period:
|
Combined budget for 2 equal & complementary partnership applications: $275,000/direct costs year 01 (addnl.
yrs. incl. 3% COLA)
4 years
|
Eligibility:
|
Established Faculty
|
Contact:
|
Linda Nolan,
(x6071)
|
RFA Link:
|
PAR-13-068 |
|
|
Feb 20 |
Established Investigators |
Federal |
CANCER SPORES |
Specialized Programs of Excellence (SPOREs)in Human Cancers for Year 2014 (P50)
Research must be translational in nature and focused on knowledge of human biology stemming from
research using cellular, molecular, structural, biochemical, and/or genetic experimental approaches with the goal of a human endpoint w/in the grant period.
Due Date:
|
February 20 (also May 20 and September 23)
|
Amount & Project Period:
|
$2,300,000/year (Total Costs)
5 years
|
Eligibility:
|
Established Investigators
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
PAR-14-031
|
|
|
Feb 20 |
All Faculty |
Federal |
Biospecimens |
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01)
To advance research in cancer etiology and early detection biomarkers, utilizing the advantages of the unique biorepository resources of the NCI-sponsored
Prostate, Lung, Colorectal, and Ovarian Cancer (PLCO) Screening Trial.
Due Date:
|
February 20
|
Amount & Project Period:
|
Budgets are not limited - 5 years
|
Eligibility:
|
All faculty
|
Contact:
|
Linda Nolan,
(x6071)
|
RFA Link:
|
PAR-13-036
|
|
|
Feb 28 |
All Ranks |
Non-federal |
Bone Marrow Failure |
2014 Research Grants
Topic areas for aplastic anemia, MDS, or PNH:
• Promote understanding of the etiology and pathogenesis;
• Improve symptom management & quality of life;
• Discover new treatments;
• Understand & prevent complications of bone marrow failure conditions (e.g., blood clotting/thrombosis in PNH, iron overload in MDS, etc).
Due Date:
|
February 28
|
Amount & Project Period:
|
$30,000/year (TOTAL)
2 years
|
Eligibility:
|
New Investigators: Postdocs, Instructors, and assistant professors with fewer than 5 years.
Established Investigators: have been assistant professors for 5 years or more or are associate or full professors
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
2014 Research Grant Guidelines
|
|
New Funding Opportunity Announcement (FOA)Number |
Feb 28 |
All Ranks |
Federal |
Cancer Research |
NCI Small Grants Program for Cancer Research
The R03 grant mechanism supports different types of projects including pilot and feasibility studies;
secondary analysis of existing data; small, self-contained research projects; development of research
methodology; and development of new research technology. It supports small projects on cancer that can be carried out in a short
period of time with limited resources.
Due Date:
|
February 28
|
Amount & Project Period:
|
$50,000/yr. (Direct Costs) - 2 years
|
Eligibility:
|
All Ranks
|
Contact:
|
Linda Nolan,
(x6071)
|
RFA Link:
|
PAR-14-007
|
|
NEW OPPORTUNITY |
March 01 |
Jr. Faculty |
Non-federal |
Cancer Research |
The AAAS MARTIN AND ROSE WACHTEL CANCER RESEARCH AWARD
Honors an early-career investigator who has performed outstanding work in the field of cancer research.
|
NEW OPPORTUNITY
LIMITED
SUBMISSION
CONTACT
SHAINA SINE |
March 01 |
Postdocs/Fellows |
Non-federal |
Cancer Research |
Ladies Auxiliary to the Veterans of Foreign Wars - Postdoctoral cancer Research Fellowship
Support for an individual engaged in any area of cancer research.
Due Date:
|
March 01
|
Amount & Project Period:
|
$50,000/year - 2 years
|
Eligibility:
|
Postdocs/Fellows -
Qualified in a specific cancer-related specialty.
Doctoral Degree conferred by July 1, 2014.
Must be US citizen
|
Contact:
|
Shaina Sine
(x3658) |
RFA Link:
|
Program Announcement and Guidelines
|
|
CYCLE I - RENEWALS,
RESUBMISSIONS, REVISIONS |
March
05 |
All Ranks |
Federal |
R01 Projects |
Research Project Grants (R01)
Cycle I due date for all renewal, resubmission, and revision applications for investigator-initiated R01 funding.
Due Date:
|
March 5
|
Amount & Project Period:
|
Budgets are not limited - 3-5 years duration
|
Eligibility:
|
All Ranks
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
PA-13-302
|
|
SPRING 2014 CYCLE |
Mar 7 (LOI)
May 6 (App) |
All Ranks |
Non-federal |
PCOR |
Patient Centered Outcomes Research Institute - Spring Cycle 2014
1.
Assessment of Prevention, Diagnosis, and Treatment Options
To address critical decisions facing patients, caregivers, and clinicians without adequate information.
2.
Improving Healthcare Systems - Comparative effectiveness research (CER) designed to provide information that would inform critical decisions that face healthcare system leaders, policy makers, clinicians, patients and caregivers
3.
Communication and Dissemination Research - To address critical knowledge gaps in the communication and dissemination process
4.
Addressing Disparities - Comparative effectiveness studies evaluating & comparing new and alternative interventions with each other or with usual care to reduce or eliminate disparities in health and health care.
5.
Improving Methods for Conducting Patient-Centered Outcomes Research - To address gaps in methodological research relevant to conducting PCOR.
FINAL DUE DATE FOR THIS FUNDING OPPORTUNITY ANNOUNCEMENT |
March 13 |
Clinical Faculty |
Federal |
CTs - Imaging |
Early Phase Clinical Trials in Imaging and Image-guided Interventions (R21)
Clinical trials for preliminary evaluation of safety and efficacy of imaging agents; assessment of imaging systems,
image processing, image-guided therapy, contrast kinetic modeling, and 3-D reconstruction and other quantitative tools.
Due Date:
|
March 13
|
Amount & Project Period:
|
$250,000/year (Direct Costs) - 2 years
|
Eligibility:
|
All Clinical Ranks
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
PAR-11-216
|
|
Cycle I Due Date for renewals, resubmissions, revisions to R21, R03, R21/R33, etc. |
March 16 |
All Ranks |
Federal |
Other Research Projects |
Other Research Grants
Cycle I deadline for renewal, resubmission, and revision applications for R03, r21, R21/R33, R34 & R36 funding mechanisms,
unless date is specifically noted in the Funding Opportunity Announcement.
|
|
Mar 20 |
Jr. Faculty |
Non-federal |
Brain Cancers |
2014 Distinguished Scientist Awards
Research focus on increased survival rates and improved recovery for patients and a cure or at the very least, treatments to make brain cancer a manageable chronic disease.
|
NEW OPPORTUNITY |
March 20 |
All Ranks |
Federal |
Nutrigenomics |
Nutrigenetics and Nutrigenomics Approaches for Nutrition Research (R01)
To promote application of nutrigenetics and/or nutrigenomics approaches to nutrition research through
collaborative interaction among nutrition researchers and experts on omics technologies.
Due Date:
|
March 20
|
Amount & Project Period:
|
Budget not limited - 5 years
|
Eligibility:
|
All Ranks
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
PAR-13-375
|
|
NEW OPPORTUNITY |
March 22 (LOI)
April 22 (Applications) |
All Faculty |
Federal |
HIV/AIDS |
U.S. - South Africa Program for Collaborative Biomedical Research (R01 & R21)
To establish a new U.S.-South Africa Program for Collaborative Biomedical Research. Areas include TB, HIV/AIDS biomedical and
behavioral science, and HIV-related co-morbidities, including malignancies.
Due Date:
|
March 22 (Letter of Intent)
April 22 (Applications)
|
Amount & Project Period:
|
R01: $350,000 (TOTAL COSTS) - 5 years
R21: $275,000 (Total DIRECT Costs) - 2 years
(Minimum 50% of total cost budget apportioned to South Africa site. |
Eligibility:
|
All Faculty
|
Contact:
|
Linda Nolan, x6071
|
RFA Link:
|
R01:
RFA-AI-14-009
R21:
RFA-AI-14-010 |
|
NEW OPPORTUNITY |
March 28 |
Faculty |
Non-federal |
Therapeutic Radiation |
ASTRO/ROI Comparative Effectiveness Research Award
Evaluation of effectiveness, complication profile, costs and cost-effectiveness of various radiation therapy treatments, and the comparative
effectiveness when compared to other therapies.
|
NEW OPPORTUNITY |
March 28 |
Jr. Faculty |
Non-federal |
Therapeutic Radiation |
Junior Faculty Career Research Training Award
Support for focused time for research projects in radiation oncology, biology, physics or outcomes/health services.
|
Toolbox |
|
Questions?
MRISignals@moffitt.org
|
|
| | | | |